These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Clinical Outcome
12 results:

  • 1. Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Harpain F; Dawoud C; Wimmer K; Schlager L; Kirchnawy S; Rizk D; Girgis K; Mittermair E; Oberndorfer F; Wöran K; Riss S; Stift A; Stift J
    Ann Surg Oncol; 2023 Jun; 30(6):3517-3527. PubMed ID: 36757514
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic Landscape of Primary Tumor Site and clinical outcome for Patients with Metastatic colorectal cancer Receiving Standard-of-Care Chemotherapy.
    Mizukami T; Takahashi M; Sunakawa Y; Yuki S; Kagawa Y; Takashima A; Kato K; Hara H; Denda T; Yamamoto Y; Shiozawa M; Oki E; Okamoto W; Yoshino T; Eguchi Nakajima T
    Target Oncol; 2022 May; 17(3):343-353. PubMed ID: 35524872
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A clinical trial of somatic and germline analyses for healthy longevity in a postoperative cancer patient.
    Hayashi N; Kuroda Y; Saito T; Tsuruda Y; Niida A; Otsu H; Eguchi H; Masuda T; Suzuki Y; Natsugoe S; Mimori K
    Surg Today; 2019 Sep; 49(9):738-747. PubMed ID: 30843125
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. smad4 Loss in colorectal cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance.
    Wasserman I; Lee LH; Ogino S; Marco MR; Wu C; Chen X; Datta J; Sadot E; Szeglin B; Guillem JG; Paty PB; Weiser MR; Nash GM; Saltz L; Barlas A; Manova-Todorova K; Uppada SPB; Elghouayel AE; Ntiamoah P; Glickman JN; Hamada T; Kosumi K; Inamura K; Chan AT; Nishihara R; Cercek A; Ganesh K; Kemeny NE; Dhawan P; Yaeger R; Sawyers CL; Garcia-Aguilar J; Giannakis M; Shia J; Smith JJ
    Clin Cancer Res; 2019 Mar; 25(6):1948-1956. PubMed ID: 30587545
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Significance of positive and inhibitory regulators in the TGF-β signaling pathway in colorectal cancers.
    Coates RF; Gardner JA; Gao Y; Cortright VM; Mitchell JM; Ashikaga T; Skelly J; Yang MX
    Hum Pathol; 2017 Aug; 66():34-39. PubMed ID: 28601657
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.
    van den Broek E; Krijgsman O; Sie D; Tijssen M; Mongera S; van de Wiel MA; Belt EJ; den Uil SH; Bril H; Stockmann HB; Ylstra B; Carvalho B; Meijer GA; Fijneman RJ
    Oncotarget; 2016 Nov; 7(45):73876-73887. PubMed ID: 27729614
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.
    Bacolod MD; Barany F
    J Mol Diagn; 2010 Sep; 12(5):552-61. PubMed ID: 20709793
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Presence of a high amount of stroma and downregulation of smad4 predict for worse survival for stage I-II colon cancer patients.
    Mesker WE; Liefers GJ; Junggeburt JM; van Pelt GW; Alberici P; Kuppen PJ; Miranda NF; van Leeuwen KA; Morreau H; Szuhai K; Tollenaar RA; Tanke HJ
    Cell Oncol; 2009; 31(3):169-78. PubMed ID: 19478385
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
    Hornick JL; Farraye FA; Odze RD
    Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer.
    Storojeva I; Boulay JL; Ballabeni P; Buess M; Terracciano L; Laffer U; Mild G; Herrmann R; Rochlitz C
    Oncology; 2005; 68(2-3):246-55. PubMed ID: 16015041
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.
    Xie W; Rimm DL; Lin Y; Shih WJ; Reiss M
    Cancer J; 2003; 9(4):302-12. PubMed ID: 12967141
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
    Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.